Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease
Description
This week, we round out our AML series with a detailed discussion about the approach to management of relapsed and refractory disease. This has been a VERY long road going through all management of AML. We hope that you have continued to build on our discussions week-to-week. An exciting treatment paradigm that is ever-evolving!
Episode contents:
- How do we define primary induction failure in AML?
- What are options for treatment of refractory disease? What is the mechanism of action of these treatment options?
- What are options for relapsed disease?
- What targeted therapies are available for relapsed AML?
****This episode is sponsored by our global research partners! Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
United States
